ICP
RMD icon

Ilex Capital Partners’s ResMed RMD Stock Holding History

Ilex Capital Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69.3M Sell
355,754
-58,101
-14% -$12M 1.42% 25
2026
Q1 		$92.9M Buy
413,855
+167,849
+68% +$41.8M 2.29% 16
2025
Q4 		$59.3M Buy
246,006
+153,121
+165% +$39.2M 1.67% 24
2025
Q3 		$25.4M Sell
92,885
-59,462
-39% -$16.2M 0.81% 40
2025
Q2 		$39.3M Buy
+152,347
New +$36.3M 1.3% 30

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Ilex Capital Partners's RMD Position: Q2 2026 in Review

Ilex Capital Partners reduced its ResMed (RMD) stake by 14% in Q2 2026, selling an estimated $12M and leaving 355,754 shares worth $69.3M. The position accounts for 1.42% of the portfolio, ranked #25.

Ilex Capital Partners first reported a position in RMD in Q2 2025 and has held it in 5 quarters since. The position peaked at $92.9M in Q1 2026. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Ilex Capital Partners held 355,754 shares of ResMed worth $69.3M as of Q2 2026.
  • Ilex Capital Partners sold 58,101 ResMed shares in Q2 2026, an estimated $12M.
  • ResMed made up 1.42% of Ilex Capital Partners's portfolio in Q2 2026, its #25 holding.
  • Ilex Capital Partners first reported a position in ResMed in Q2 2025 and has held it in 5 quarters since.
  • Ilex Capital Partners's ResMed position peaked at $92.9M in Q1 2026.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Ilex Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.